These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 15236118)

  • 1. [A simple method, for tear production stimulation in dry eye].
    Petranyi P
    Klin Monbl Augenheilkd; 2004 Jun; 221(6):520. PubMed ID: 15236118
    [No Abstract]   [Full Text] [Related]  

  • 2. [The dry eye].
    Kaszli FA
    Med Monatsschr Pharm; 1995 Apr; 18(4):97-9. PubMed ID: 7752989
    [No Abstract]   [Full Text] [Related]  

  • 3. On call. I have recently noticed that my eyes are frequently dry. I have used saline eye drops, but they don't seem to help much. Is this normal?
    Kormos W
    Harv Mens Health Watch; 2012 Dec; 17(5):2. PubMed ID: 23373109
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative costs of various preserved artificial tear solutions for the treatment of dry eye conditions.
    Enzenauer RW; Kao A; Williams T; Lambert RW
    Eye Contact Lens; 2003 Oct; 29(4):238-40. PubMed ID: 14555900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is there an universal artificial tear?].
    Turu L
    Oftalmologia; 2012; 56(1):14-9. PubMed ID: 22888681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM; McDonald MB; Smolek M
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What to do when the tears dry up.
    Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):7. PubMed ID: 20336848
    [No Abstract]   [Full Text] [Related]  

  • 8. SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.
    Burgess PI; Koay P; Clark P
    Cornea; 2008 May; 27(4):391-4. PubMed ID: 18434839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lacrimation blocking technique in the treatment of severe "dry eye" syndrome].
    Senchikhin MV
    Vestn Oftalmol; 2005; 121(4):39-41. PubMed ID: 16223044
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lacrimal film evolution in eye with prosthesis].
    Murariu L
    Oftalmologia; 2006; 50(2):115-20. PubMed ID: 16927769
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of topically administered atropine on tear production in dogs.
    Hollingsworth SR; Canton DD; Buyukmihci NC; Farver TB
    J Am Vet Med Assoc; 1992 May; 200(10):1481-4. PubMed ID: 1612982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of topical pilocarpine treatment on tear production in dogs.
    Smith EM; Buyukmihci NC; Farver TB
    J Am Vet Med Assoc; 1994 Nov; 205(9):1286-9. PubMed ID: 7698938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The scientific context and basis of the pharmacologic management of dry eyes.
    Gilbard JP
    Ophthalmol Clin North Am; 2005 Dec; 18(4):475-84, v. PubMed ID: 16314213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dry eyes. Tears absent only rarely].
    Deutsches Grünes Kreuz
    Kinderkrankenschwester; 2005 Sep; 24(9):373. PubMed ID: 16218094
    [No Abstract]   [Full Text] [Related]  

  • 15. [Method for prolongation of the action of eye drops].
    Sultanov MIu
    Oftalmol Zh; 1974; 29(7):545-7. PubMed ID: 4437873
    [No Abstract]   [Full Text] [Related]  

  • 16. Dry eye in Waldenström's macroglobulinemia. Improvement after systemic chemotherapy.
    Cordido M; Fernández-Lago C; Fernández-Vigo J; López-Nieto C
    Cornea; 1995 Mar; 14(2):210-1. PubMed ID: 7743807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artificial tears on tear stress test.
    Khanal S; Simmons PA; Pearce EI; Day M; Tomlinson A
    Optom Vis Sci; 2008 Aug; 85(8):732-9. PubMed ID: 18677237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab eye drop treatment stimulates tear secretion in rats through changes in VEGF and NGF lacrimal gland levels.
    Rossi S; Mantelli F; Lambiase A; Aloe L
    Arch Ital Biol; 2012 Mar; 150(1):15-21. PubMed ID: 22786834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular safety of INS365 ophthalmic solution: a P2Y(2) agonist in healthy subjects.
    Mundasad MV; Novack GD; Allgood VE; Evans RM; Gorden JC; Yerxa BR
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):173-9. PubMed ID: 11324984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.